Knockdown of ACAT-1 reduces amyloidogenic processing of APP

Abstract: Previous studies have shown that acyl-coenzyme A:cholesterol acyl transferase (ACAT), an enzyme that controls cellular equilibrium between free cholesterol and cholesteryl esters, modulates proteolytic processing of APP in cell-based and animal models of Alzheimer’s disease. Here we report that ACAT-1 RNAi reduced cellular ACAT-1 protein by ∼50% and cholesteryl ester levels by 22% while causing a slight increase in the free cholesterol content of ER membranes. This correlated with reduced proteolytic processing of APP and 40% decrease in Aβ secretion. These data show that even a modest decrease in ACAT activity can have robust suppressive effects on Aβ generation. [Copyright &y& Elsevier]